Company Filing History:
Years Active: 2017
Title: Rhett P Ketterling: Innovator in Cancer Research
Introduction
Rhett P Ketterling is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of cancer research, particularly in the detection of genetic translocations associated with various cancers. His work is vital for advancing medical understanding and treatment options.
Latest Patents
Ketterling holds a patent for the detection of TBL1XR1 and TP63 translocations. This patent provides methods and materials involved in detecting translocations of TBL1XR1 and TP63 nucleic acid. Specifically, it includes methods for identifying gene rearrangements associated with cancers, such as T-cell lymphomas, and offers insights into cancers with a dominant negative TP63 phenotype. He has 1 patent to his name.
Career Highlights
Ketterling is affiliated with the Mayo Foundation for Medical Education and Research, where he applies his expertise in genetic research. His work has been instrumental in developing diagnostic tools that can lead to better patient outcomes in oncology.
Collaborations
Throughout his career, Ketterling has collaborated with esteemed colleagues, including George Vasmatzis and Andrew L Feldman. These partnerships have enhanced the scope and impact of his research in the medical field.
Conclusion
Rhett P Ketterling's innovative work in cancer research exemplifies the importance of genetic studies in improving diagnostic methods. His contributions continue to influence the medical community and pave the way for future advancements in cancer treatment.